Mitsui Chemicals, Inc.
Notice Regarding Transfer of a Specified Subsidiary
In line with Ultradent acquisition, Ultradent becomes a specified subsidiary. Through in-kind contribution, the ownership ratio exceeds 10% of capital, resulting in specified subsidiary status. The anticipated impact on future performance is minor, and disclosure will be made if additional grounds for disclosure arise.
Key Figures
- In-kind contributed amount: 96.0 million USD (in-kind contributed by Ultradent)
- Ultradent’s last three years' consolidated net sales: 346.0/351.8/372.1 million USD
- Ultradent’s last three years' consolidated operating income: 29.4/25.6/30.9 million USD
AI要約
Background and Details
Mitsui Chemicals, Inc. completed the acquisition of U.S.-based Ultradent Products, Inc. through Mitsui Chemicals America, Inc., which established MC Dental Holdings America, Inc. to acquire Ultradent’s shares and business assets. Subsequently, in-kind contribution procedures were carried out to make Ultradent a specified subsidiary through its capital relationships.
Outlook and Impact
The impact of Ultradent becoming a specified subsidiary on our group’s performance is expected to be minimal, and any future additional disclosure grounds will be promptly announced. Changes in key financial indicators are currently limited.
Mitsui Chemicals, Inc.
Company overview · Stock price · Financial data · All IR
